Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Volatile organic compounds as disease predictors in newborn infants: a systematic review

Course, Christopher, Watkins, W. John ORCID:, Müller, Carsten T. ORCID:, Odd, David ORCID:, Kotecha, Sailesh ORCID: and Chakraborty, Mallinath 2021. Volatile organic compounds as disease predictors in newborn infants: a systematic review. Journal of Breath Research 15 (2) , 024002. 10.1088/1752-7163/abe283

[thumbnail of Course_2021_J._Breath_Res._15_024002.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (794kB)


Volatile organic compounds (VOCs) detected in human breath, urine, stool, sweat, saliva, and blood result from metabolic processes in the body during health or disease. Using sophisticated measurement systems, small amounts of these compounds can be detected in the above bodily fluids. Multiple studies in adults and children have shown the potential of these compounds to differentiate between healthy individuals and patients by detecting profiles of compounds in non-invasively collected samples. However, the detection of biomarkers in VOCs from neonates is particularly attractive due to the non-invasive nature of its approach, and its ability to track disease progress by longitudinal sampling. In this work we have reviewed the literature on the use of VOCs in neonates and identified areas for future work. Overview of VOCs and their usefulness as metabolic signatures. Detailed review of studies on VOCs in neonates Learn about potential uses of VOCs as derived from adult and paediatric studies. Examine current limitations and identify future work. Detailed studies on VOCs involving neonatal patients including sick preterm infants and term infants with specific morbidities are needed. These studies should collect longitudinal samples using non-invasive methods for the detection of potential biomarkers. Underlying metabolic processes need to be identified so that any therapeutic options can be clarified.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: IOP Publishing: Hybrid Open Access
ISSN: 1752-7155
Date of First Compliant Deposit: 26 February 2021
Date of Acceptance: 2 February 2021
Last Modified: 10 Nov 2023 02:07

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics